![Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/181/1/146/F1.large.jpg)
Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
![Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/181/1/146/F5.large.jpg)
Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
![Cancers | Free Full-Text | Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancers | Free Full-Text | Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)](https://www.mdpi.com/cancers/cancers-13-00286/article_deploy/html/images/cancers-13-00286-g002-550.jpg)
Cancers | Free Full-Text | Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
![Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/181/1/146/F3.large.jpg)
Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
![PDF) Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) PDF) Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)](https://i1.rgstatic.net/publication/348497226_Patterns_of_Response_to_Immune_Checkpoint_Inhibitors_in_Association_with_Genomic_and_Clinical_Features_in_Patients_with_Head_and_Neck_Squamous_Cell_Carcinoma_HNSCC/links/6018c35545851517ef31ee9f/largepreview.png)
PDF) Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
![Cancers | Free Full-Text | Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancers | Free Full-Text | Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)](https://www.mdpi.com/cancers/cancers-13-00286/article_deploy/html/images/cancers-13-00286-g002.png)
Cancers | Free Full-Text | Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
![Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/181/1/146/F2.large.jpg)